Scott R M, Dudding B A, Romano S V, Russell P K
Infect Immun. 1972 Mar;5(3):300-4. doi: 10.1128/iai.5.3.300-304.1972.
Studies of the immunologic responses following administration of a live, enteric-coated adenovirus (ADV) type 21 vaccine showed that nine of ten vaccinees and none of five controls developed neutralizing antibody. Antibody activity of serum and secretory immunoglobulins was assayed by using a (14)C-labeled ADV-21 antigen in a radioimmunodiffusion system. Increases in immunoglobulin M, A and G (IgM, IgA, IgG) activity were detected in sera from vaccinees but not in those from controls. IgA copro antibody activity was also shown in vaccinees but not in controls. Nasal secretions showed no detectable IgA antibody responses by this method. These studies show marked differences in serum and local IgA antibody activity in induced enteric ADV infection compared to previously reported responses after natural infection. The protective role of secretory IgA in adenovirus infections is obscure. However, absence of nasal IgA responses may indicate that protection against disease with enteric ADV vaccines depends primarily upon humoral antibody.
对21型活肠溶腺病毒(ADV)疫苗接种后的免疫反应研究表明,十名接种疫苗者中有九人产生了中和抗体,而五名对照者均未产生。血清和分泌型免疫球蛋白的抗体活性通过在放射免疫扩散系统中使用(14)C标记的ADV - 21抗原进行测定。在接种疫苗者的血清中检测到免疫球蛋白M、A和G(IgM、IgA、IgG)活性增加,而在对照者血清中未检测到。接种疫苗者中也显示出IgA粪便抗体活性,而对照者中未显示。通过该方法在鼻分泌物中未检测到可检测到的IgA抗体反应。这些研究表明,与先前报道的自然感染后的反应相比,在诱导的肠道ADV感染中血清和局部IgA抗体活性存在显著差异。分泌型IgA在腺病毒感染中的保护作用尚不清楚。然而,鼻IgA反应的缺失可能表明,肠道ADV疫苗对疾病的保护主要依赖于体液抗体。